Ratings by Laidlaw (Yale Jen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/19/2024 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.14 (1.04) |
-8.77% | Details | |
| 3/13/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | Cingulate | CING | Downgrade | Hold (Buy) |
2.15 (0.84) |
-60.93% | Details | |
| 12/5/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2023 | Silo Pharma | SILO | New Coverage | Buy (N/A) |
1.90 (1.88) |
-1.05% | Details | |
| 8/15/2023 | Alaunos Therapeutics Inc. | TCRT | Downgrade | Hold (Buy) |
0.39 (1.16) |
197.44% | Details | |
| 6/6/2023 | Bellerophon Therapeutics | BLPH | Downgrade | Hold (Buy) |
7.06 (0.10) |
-98.58% | Details | |
| 5/16/2023 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Bellerophon Therapeutics | BLPH | New Coverage | Buy (N/A) |
9.07 (0.10) |
-98.9% | Details | |
| 9/6/2022 | NLS Pharmaceutics | NLSP | New Coverage | Buy (N/A) |
0.51 (0.13) |
-74.51% | Details | |
| 6/23/2022 | F-Star Therapeutics Inc. | FSTX | Downgrade | Hold (Buy) |
3.98 (7.12) |
78.89% | Details | |
| 6/6/2022 | Curis | CRIS | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2022 | Evofem Biosciences Inc | EVFM | New Coverage | Buy (N/A) |
0.35 (0.48) |
37.14% | Details | |
| 5/10/2022 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2022 | Cingulate | CING | New Coverage | Buy (N/A) |
2.58 (0.84) |
-67.44% | Details | |
| 12/16/2021 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2021 | Taiwan Liposome Co Ltd. | TLC | Downgrade | Hold (Buy) |
5.73 (7.00) |
22.16% | Details | |
| 6/29/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Carpenter Technology | CRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | aTyr Pharma | LIFE | New Coverage | Buy (N/A) |
3.82 (1.60) |
-58.12% | Details | |
| 4/6/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2021 | F-Star Therapeutics Inc. | FSTX | New Coverage | Buy (N/A) |
11.59 (7.12) |
-38.57% | Details | |
| 3/10/2021 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2021 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2020 | Curis | CRIS | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2020 | BioSig Technologies, Inc | BSGM | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2020 | Onconova Therapeutics | ONTX | Downgrade | Hold (Buy) |
1.01 (1.00) |
-0.99% | Details | |
| 7/31/2020 | Opko Health | OPK | Maintain | Buy () |
|
Details | ||
| 7/29/2020 | Curis | CRIS | New Coverage | Buy (N/A) |
1.26 (14.52) |
1052.38% | Details | |
| 2/19/2020 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2019 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
1.73 (37.34) |
2058.38% | Details | |
| 11/4/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Buy (N/A) |
2.37 (16.16) |
581.86% | Details | |
| 8/9/2019 | Sesen Bio, Inc | SESN | Downgrade | Hold (Buy) |
1.17 (0.63) |
-46.15% | Details | |
| 7/3/2019 | Affimed Therapeutics | AFMD | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2019 | Hoth Therapeutics | HOTH | New Coverage | Buy (N/A) |
5.50 (1.17) |
-78.73% | Details | |
| 4/1/2019 | ZIOPHARM Oncology | ZIOP | New Coverage | Buy (N/A) |
3.76 (0.87) |
-76.86% | Details | |
| 3/25/2019 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2019 | Fennec Pharmaceuticals Inc. | FENC | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2018 | Onconova Therapeutics | ONTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2018 | Molecular Templates | MTEM | New Coverage | Buy (N/A) |
5.42 (1.60) |
-70.48% | Details | |
| 8/31/2018 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details |
